These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
131 related articles for article (PubMed ID: 6604945)
1. [Efficacy of the treatment of patients with protracted rheumatism with quinolines]. Siurin AA; Skorobatskiĭ VS Sov Med; 1983; (7):84-6. PubMed ID: 6604945 [No Abstract] [Full Text] [Related]
2. [Principle of immunoregulation in the treatment of chronic inflammatory rheumatism]. Duţu A; Boloşiu HD Rev Med Interna Neurol Psihiatr Neurochir Dermatovenerol Med Interna; 1984; 36(3):193-203. PubMed ID: 6084276 [No Abstract] [Full Text] [Related]
3. [Anti-allergic and immunosuppressive treatment of rheumatism and rheumatoid arthritis]. Tsenov I Vutr Boles; 1972; 11(3):131-2. PubMed ID: 4154529 [No Abstract] [Full Text] [Related]
5. [The treatment of chronic inflammatory rheumatism by immunosuppressives (proceedings)]. Prieur AM; Balafrej M; Griscelli C; Mozziconacci P Arch Fr Pediatr; 1977 Oct; 34(8):783-7. PubMed ID: 303890 [No Abstract] [Full Text] [Related]
6. [Effect of combined treatment of latent rheumatism and rheumatoid arthritis on the serotonin-binding capacity of thrombocytes]. Matulis AA; Pliushkis AI Vopr Revm; 1974; (4):20-2. PubMed ID: 4548603 [No Abstract] [Full Text] [Related]
7. [Immune reactivity in patients with torpid rheumatism and infectious-allergic myocarditis]. Mitchenko EI Vrach Delo; 1983 Jun; (6):27-30. PubMed ID: 6604995 [No Abstract] [Full Text] [Related]
8. [Health resort therapy in stage-by-stage treatment of patients with active rheumatism]. Mikhaĭlova IN; Bronzov IA; Milaeva LV Vopr Revm; 1974; (4):42-8. PubMed ID: 4548605 [No Abstract] [Full Text] [Related]
10. [Clinical and pathogenetic characteristics of acute and protracted rheumatism]. Nasonova VA; Bronzov IA; Mikhaĭlova IN; Kaĭnova AS; Sushkov IuN Klin Med (Mosk); 1980 Sep; 58(9):23-9. PubMed ID: 6967999 [No Abstract] [Full Text] [Related]
11. [Treatment trials of chronic rheumatism with a synthetic antimalarial quinoline derivative]. LACAPERE J; MONIER H; VIAL G Rev Rhum Mal Osteoartic; 1954 May; 21(5):389-94. PubMed ID: 13186618 [No Abstract] [Full Text] [Related]
12. [The blood coagulation status and the immunochemical and clinical indices in patients with active rheumatism during treatment with nerobol]. Likhatskaia VA; Epishin AV; Furtel' PA Lab Delo; 1991; (8):42-4. PubMed ID: 1724507 [TBL] [Abstract][Full Text] [Related]
13. [Immunosupression and viral infections in rheumatic diseases]. Vince A; Dusek D Reumatizam; 2007; 54(2):58-62. PubMed ID: 18351141 [TBL] [Abstract][Full Text] [Related]
14. [Cyclosporin A in inflammatory rheumatic diseases]. Gross WL; Rob PM Internist (Berl); 1996 Jan; 37(1):91-7. PubMed ID: 8837835 [No Abstract] [Full Text] [Related]
15. Progressive multifocal leukoencephalopathy in patients with rheumatic diseases: are patients with systemic lupus erythematosus at particular risk? Molloy ES; Calabrese LH Autoimmun Rev; 2008 Dec; 8(2):144-6. PubMed ID: 18700172 [TBL] [Abstract][Full Text] [Related]
16. Risks of immunosuppressive therapies including biologic agents in patients with rheumatic diseases and co-existing chronic viral infections. Vassilopoulos D; Calabrese LH Curr Opin Rheumatol; 2007 Nov; 19(6):619-25. PubMed ID: 17917544 [TBL] [Abstract][Full Text] [Related]
17. [Alterations of some factors of non-specific immunity in chronic tonsillitis in patients with various degrees of rheumatism activity]. Grinevich IuA; Ptukha RM Zh Ushn Nos Gorl Bolezn; 1969; 29(6):17-20. PubMed ID: 5310553 [No Abstract] [Full Text] [Related]
18. Immune status and risk for infection in patients receiving chronic immunosuppressive therapy. Glück T; Kiefmann B; Grohmann M; Falk W; Straub RH; Schölmerich J J Rheumatol; 2005 Aug; 32(8):1473-80. PubMed ID: 16078322 [TBL] [Abstract][Full Text] [Related]